Free Trial

Syra Health (SYRA) Competitors

Syra Health logo
$0.08 -0.02 (-16.76%)
As of 11:23 AM Eastern

SYRA vs. TNMG, ISPC, TC, MRIN, STAF, AUUD, LICN, LYT, DKDCA, and HAO

Should you be buying Syra Health stock or one of its competitors? The main competitors of Syra Health include TNL Mediagene - Ordinary Shares (TNMG), iSpecimen (ISPC), TuanChe (TC), Marin Software (MRIN), Staffing 360 Solutions (STAF), Auddia (AUUD), Lichen China (LICN), Lytus Technologies Holdings PTV. (LYT), Data Knights Acquisition (DKDCA), and Haoxi Health Technology (HAO). These companies are all part of the "business services" industry.

Syra Health vs. Its Competitors

Syra Health (NASDAQ:SYRA) and TNL Mediagene - Ordinary Shares (NASDAQ:TNMG) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, community ranking, earnings, analyst recommendations, dividends and valuation.

4.8% of Syra Health shares are owned by institutional investors. 10.2% of Syra Health shares are owned by insiders. Comparatively, 41.0% of TNL Mediagene - Ordinary Shares shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

TNL Mediagene - Ordinary Shares has a consensus price target of $3.50, suggesting a potential upside of 295.66%. Given TNL Mediagene - Ordinary Shares' stronger consensus rating and higher possible upside, analysts plainly believe TNL Mediagene - Ordinary Shares is more favorable than Syra Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Syra Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
TNL Mediagene - Ordinary Shares
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

TNL Mediagene - Ordinary Shares received 1 more outperform votes than Syra Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Syra HealthN/AN/A
TNL Mediagene - Ordinary SharesOutperform Votes
1
100.00%
Underperform Votes
No Votes

Syra Health has a beta of 3.58, meaning that its share price is 258% more volatile than the S&P 500. Comparatively, TNL Mediagene - Ordinary Shares has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500.

TNL Mediagene - Ordinary Shares has higher revenue and earnings than Syra Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Syra Health$7.98M0.11-$2.94M-$0.36-0.21
TNL Mediagene - Ordinary Shares$48.49M0.12N/AN/AN/A

In the previous week, TNL Mediagene - Ordinary Shares had 3 more articles in the media than Syra Health. MarketBeat recorded 3 mentions for TNL Mediagene - Ordinary Shares and 0 mentions for Syra Health. TNL Mediagene - Ordinary Shares' average media sentiment score of 0.64 beat Syra Health's score of 0.00 indicating that TNL Mediagene - Ordinary Shares is being referred to more favorably in the news media.

Company Overall Sentiment
Syra Health Neutral
TNL Mediagene - Ordinary Shares Positive

TNL Mediagene - Ordinary Shares has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. TNL Mediagene - Ordinary Shares' return on equity of 0.00% beat Syra Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Syra Health-54.90% -131.94% -99.19%
TNL Mediagene - Ordinary Shares N/A N/A N/A

Summary

TNL Mediagene - Ordinary Shares beats Syra Health on 12 of the 14 factors compared between the two stocks.

Get Syra Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYRA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SYRA vs. The Competition

MetricSyra HealthEmployment agencies IndustryMedical SectorNASDAQ Exchange
Market Cap$856K$810.79M$5.62B$8.58B
Dividend YieldN/A2.07%5.28%4.17%
P/E Ratio-0.127.6127.1919.81
Price / Sales0.111.12408.23154.60
Price / CashN/A9.8538.3234.64
Price / Book0.121.506.994.65
Net Income-$2.94M$43.13M$3.23B$248.05M
7 Day PerformanceN/A-5.10%-0.18%-0.26%
1 Month PerformanceN/A7.10%8.61%4.37%
1 Year PerformanceN/A-25.05%32.26%13.65%

Syra Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYRA
Syra Health
N/A$0.08
-16.8%
N/A-94.1%$856K$7.98M-0.1278Gap Down
TNMG
TNL Mediagene - Ordinary Shares
N/A$0.52
-8.1%
$3.50
+568.3%
N/A$3.75M$48.49M0.00N/A
ISPC
iSpecimen
0.5773 of 5 stars
$1.27
+0.8%
N/A+231.3%$3.15M$8.06M-0.0760Short Interest ↑
Gap Up
TC
TuanChe
0.2935 of 5 stars
$0.91
+7.1%
N/A-59.3%$2.89M$49.18M0.00620Short Interest ↑
Gap Up
MRIN
Marin Software
0.9271 of 5 stars
$0.85
+6.6%
N/A-54.5%$2.71M$16.71M-0.22180Short Interest ↓
Gap Down
High Trading Volume
STAF
Staffing 360 Solutions
N/A$1.62
flat
N/AN/A$2.66M$190.88M0.00200
AUUD
Auddia
0.7036 of 5 stars
$5.19
+2.2%
N/A-74.1%$2.65MN/A-0.1220Positive News
Short Interest ↓
LICN
Lichen China
N/A$4.31
+1.7%
N/A-98.4%$2.54M$41.48M0.00390Short Interest ↓
LYT
Lytus Technologies Holdings PTV.
N/A$0.07
-40.6%
N/A-97.4%$2.18M$23.72M0.003Gap Down
High Trading Volume
DKDCA
Data Knights Acquisition
N/A$0.39
+7.5%
N/A-67.8%$2.00MN/A-2.042Gap Up
HAO
Haoxi Health Technology
N/A$1.37
-1.4%
N/A-99.2%$1.79M$48.97M0.0029

Related Companies and Tools


This page (NASDAQ:SYRA) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners